- Biden Outlines ‘Bold’ National Vaccine Effort
- COVID Pandemic Shortened U.S. Life Expectancy by More Than a Year
- Should Your Child Get a COVID Test?
- AHA News: What Heart and Stroke Patients Should Know About COVID-19 Vaccines
- New Hope Against Diseases Marked by Progressive Scarring of Lung Tissue
- Biden Unveils $1.9 Trillion Coronavirus ‘Rescue’ Plan
- Health Highlights: Jan. 15, 2021
- Pharmacy Chains Ready to Supply COVID-19 Vaccines to Americans
- 3 Steps Could Nearly Eliminate COVID Infections on College Campuses: Study
- What Happened to the Flu This Year?
Generic Effexor XR Approved
TUESDAY, June 29The first generic version of Effexor extended release capsules (venlafaxine hydrochloride) to treat major depressive disorder has been approved by the U.S. Food and Drug Administration.
Prescribing information for the generic version of Effexor XR may differ from that of the brand name drug because of various patents held by the brand name drug’s maker, Wyeth Pharmaceuticals, the FDA said in a news release. But the same safety warnings will apply.
The generic version will be manufactured by Teva Pharmaceuticals, based in Wales, Penn.
The drug’s label includes a warning that antidepressants may raise the risk of suicidal thoughts or tendencies among some children, teens and young adults, the agency said.
More information
To learn more about this drug, visit the U.S. National Library of Medicine.
Source: HealthDay
